Skip to content
OpenCapital
Get started

Oscar Health OSCR Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)

Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) at other companies

CVS Health logo
CVS HealthCVS
——
UnitedHealth Group logo
UnitedHealth GroupUNH
——

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Cash & equivalents$4.8B+114%
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$8.56B+4.0%
Enterprise value$4.16B-174%
P/S0.6×-0.2×

Profitability

See full
Operating margin0.1%—
Net margin-0.3%—
FCF margin-8.2%—

Returns & leverage

See full
Return on equity-2.6%—
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's available-for-sale debt securities - amortized cost (due within one year).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oscar Health's available-for-sale debt securities - amortized cost (due within one year)?
Oscar Health (OSCR) reported available-for-sale debt securities - amortized cost (due within one year) of $1.99B in Q1 2026.
How has Oscar Health's available-for-sale debt securities - amortized cost (due within one year) changed year-over-year?
Oscar Health's available-for-sale debt securities - amortized cost (due within one year) increased by 165.7% year-over-year, from $750.09M to $1.99B.
What is the long-term trend for Oscar Health's available-for-sale debt securities - amortized cost (due within one year)?
Over 2 years (2023 to 2025), Oscar Health's available-for-sale debt securities - amortized cost (due within one year) has grown at a 32.5% compound annual growth rate (CAGR), from $690.69M to $1.21B.